China Competitors

Pink Sheets . USA . 
Stock . China Health Management
CNHC Stock  USD 0  0  44.12%   
China Health Management competes with Embrace Change, Alpha One, and Global Blockchain; as well as few others. The company conducts business under Technology Hardware, Storage & Peripherals sector and is part of Information Technology industry. Analyzing China Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of China Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out China Health Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of China Health competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.0112.98
Details
Intrinsic
Valuation
LowRealHigh
0.00012.97
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as China Health. Your research has to be compared to or analyzed against China Health's peers to derive any actionable benefits. When done correctly, China Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in China Health Management.

China Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between China Health and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of China and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of China Health Management does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
EMCG
+ 0.77
AHFI
AOAO
+ 0.46
TAKD
TAKD
+ 0.21
SPRV
AOAO
+ 0.08
SPRV
AHFI
+ 0.0
GLRI
EMCG
+ 0.0
GLRI
  
High negative correlations   
AOAO
- 0.57
EMCG
SPRV
- 0.55
AHFI
AOAO
- 0.47
AHFI
TAKD
- 0.38
EMCG
SPRV
- 0.35
EMCG
TAKD
- 0.33
AHFI

Risk-Adjusted Indicators

There is a big difference between China Pink Sheet performing well and China Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze China Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
GLRI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
AHFI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
EMCG  0.20  0.03  0.00  0.42  0.00 
 0.00 
 0.69 
(0.26)
 3.66 
SPRV  17.20  4.04  0.09 (0.70) 15.79 
(75.00)
 100.00 
(50.00)
 150.00 
TAKD  57.76  26.89  0.00 (1.96) 0.00 
 0.00 
 0.00 
(0.50)
 1,997 
ATAQF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
AVNY  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
APNCW  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
AOAO  1.09 (0.53) 0.00  0.41  0.00 
 0.00 
 0.00 
 0.00 
 36.55 
All Fundamental Data

China Health Competitive Analysis

The better you understand China Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, China Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across China Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CNHC AHFI EMCG SPRV TAKD AVNY AOAO GBBK
 44.12 
 0 
China
 0.00 
 0 
Absolute
 0.68 
 11.90 
Embrace
 0.00 
 0.0001 
Supurva
 0.00 
 0 
TransAKT
 0.00 
 0.0001 
Manaris
 0.00 
 1.54 
Alpha
 0.00 
 11.30 
Global
Market Volatility
(90 Days Market Risk)
Out of control
Out of control
Very steady
Out of control
Out of control
Very steady
Dangerous
Very steady
Market Performance
(90 Days Performance)
Insignificant
OK
Modest
OK
OK
Very Weak
Very Weak
Insignificant
Odds of Financial Distress
(Probability Of Bankruptcy)
High
Low
Below Average
High
Below Average
Dangerous
Quite High
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Hold
Hold
Buy
Cautious Hold
Cautious Hold
Strong Hold
Cautious Hold
Strong Hold
Current Ratio
1.09 X
N/A
0.03 X
N/A
4.82 X
0.96 X
0.82 X
N/A
Net Asset
5.2 M
N/A
56.24 M
6.81 K
239.09 K
21.34 M
N/A
26.77 M
Profit Margin
(0.24) %
N/A
N/A
N/A
N/A
(0.19) %
(2.98) %
N/A
EBITDA
N/A
N/A
2.42 M
N/A
(208.31 K)
(889.78 K)
(356.93 K)
5.56 M
Operating Margin
(0.21) %
N/A
N/A
N/A
N/A
(0.06) %
(2.97) %
N/A
Current Valuation
17.53 M
N/A
54.68 M
N/A
4.66 M
227.9 K
1.58 M
61.54 M
Price To Book
N/A
N/A
2.69 X
N/A
45.71 X
0.13 X
N/A
10.88 X
Retained Earnings
(34.26 M)
N/A
(4.11 M)
N/A
(23.18 M)
(32.41 M)
N/A
(1.57 M)
Current Asset
9.37 M
N/A
N/A
N/A
727 K
N/A
N/A
N/A
Five Year Return
N/A
N/A
(1.56) %
N/A
N/A
N/A
N/A
N/A
One Year Return
N/A
N/A
(3.61) %
N/A
N/A
N/A
N/A
N/A
Beta
1.28
345.39
0.01
28.84
-0.19
8.6
-2.62
0.04
Number Of Employees
13
N/A
N/A
8
5
193
10
N/A
Equity Positions Weight
N/A
N/A
97.03 %
N/A
N/A
N/A
N/A
N/A
Shares Outstanding
81.15 M
64.22 M
4.52 M
N/A
133.51 M
N/A
N/A
5.45 M
Three Year Return
N/A
N/A
(2.36) %
N/A
N/A
N/A
N/A
N/A
Cash Flow From Operations
N/A
N/A
(352.35 K)
(329.58 K)
(208.68 K)
(634.94 K)
(322.4 K)
(2.02 M)
Total Debt
N/A
N/A
400.11 K
740.83 K
N/A
122.42 K
173.4 K
2.2 M
Return On Equity
N/A
N/A
N/A
N/A
-1.01
-0.89
-9.54
0.48
Z Score
-8.4
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Book Value Per Share
0 X
N/A
(1.27) X
N/A
0 X
0.02 X
0.01 X
(0.45) X
Return On Asset
N/A
N/A
-0.0112
N/A
-0.57
-0.0742
-0.67
-0.0344
Number Of Shares Shorted
N/A
N/A
2.87 K
N/A
N/A
N/A
N/A
3.71 K
Current Liabilities
4.21 M
N/A
N/A
N/A
1.06 M
N/A
N/A
N/A
Total Asset
5.2 M
N/A
56.24 M
6.81 K
239.09 K
21.34 M
N/A
26.77 M
Debt To Equity
N/A
N/A
6.76 %
N/A
0.46 %
2.97 %
N/A
N/A
Short Ratio
N/A
N/A
5.19 X
N/A
N/A
N/A
N/A
21.07 X
Target Price
N/A
N/A
N/A
N/A
N/A
0.2
N/A
N/A
Last Dividend Paid
N/A
N/A
0.02
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
N/A
50.85 %
N/A
N/A
N/A
N/A
10.91 %
Market Capitalization
929.12 K
147.2 K
53.79 M
N/A
4.66 M
108.99 K
N/A
61.04 M
Price To Earning
(1.80) X
N/A
11.87 X
N/A
N/A
N/A
N/A
N/A
Price To Sales
3.18 X
N/A
N/A
N/A
N/A
0 X
N/A
N/A
Net Income
(129.28 K)
N/A
2.42 M
(304.78 K)
(208.31 K)
(3.12 M)
(326.8 K)
3.17 M
Earnings Per Share
(0) X
N/A
0.23 X
N/A
(0) X
N/A
(0.97) X
(0.03) X
Shares Owned By Insiders
N/A
N/A
49.15 %
N/A
83.38 %
N/A
N/A
79.16 %
Revenue
542.38 K
N/A
N/A
N/A
N/A
21.6 M
120.55 K
N/A
Working Capital
5.16 M
N/A
(1.53 M)
N/A
(329 K)
N/A
N/A
(1.72 M)
Cash And Equivalents
N/A
N/A
4.6 K
N/A
128.58 K
387.54 K
5.54 K
N/A
Cash Per Share
N/A
N/A
N/A
N/A
N/A
N/A
0.02 X
N/A
Gross Profit
108.47 K
N/A
N/A
N/A
N/A
7.91 M
9.96 K
N/A
Day Typical Price
0.0049
0.001
11.9
1.0E-4
0.0027
1.0E-4
1.54
11.3
Daily Balance Of Power
9.2 T
0.0
9.2 T
0.0
0.0
0.0
0.0
0.0
Period Momentum Indicator
0.0015
N/A
0.08
N/A
N/A
N/A
N/A
N/A
Rate Of Daily Change
1.44
1.0
1.01
1.0
1.0
1.0
1.0
1.0
Day Median Price
0.0049
0.001
11.9
1.0E-4
0.0027
1.0E-4
1.54
11.3
Price Action Indicator
8.0E-4
N/A
0.04
N/A
N/A
N/A
N/A
N/A
Relative Strength Index
57.25
100.0
59.85
40.83
42.12
N/A
3.5
58.29
Coefficient Of Variation
2315.14
N/A
1148.36
772.77
873.33
N/A
(861.08)
2491.31
Mean Deviation
3.85
N/A
0.2012
17.2
57.76
N/A
1.09
0.236
Jensen Alpha
0.5414
N/A
0.0296
4.04
26.89
N/A
(0.53)
0.0134
Total Risk Alpha
0.5216
N/A
0.029
3.98
26.51
N/A
(0.54)
0.0124
Sortino Ratio
N/A
N/A
N/A
0.0887
N/A
N/A
N/A
0.0088
Downside Variance
N/A
N/A
N/A
2063.49
N/A
N/A
N/A
1.93
Standard Deviation
12.77
N/A
0.4561
31.22
234.79
N/A
4.51
0.5795
Kurtosis
20.28
N/A
9.63
3.94
65.2
N/A
65.6
6.29
Potential Upside
N/A
N/A
0.6944
100.0
N/A
N/A
N/A
1.35
Treynor Ratio
3.84
N/A
0.4186
(0.70)
(1.96)
N/A
0.4114
(0.14)
Maximum Drawdown
115.9
N/A
3.66
150.0
1997.3
N/A
36.55
3.58
Variance
163.03
N/A
0.2081
974.88
55128.24
N/A
20.34
0.3358
Market Risk Adjusted Performance
3.85
N/A
0.4286
(0.69)
(1.95)
N/A
0.4214
(0.13)
Risk Adjusted Performance
0.04
N/A
0.0561
0.1014
0.0911
N/A
(0.07)
0.0262
Skewness
2.65
N/A
(0.52)
1.61
8.05
N/A
(8.09)
0.1748
Semi Deviation
N/A
N/A
N/A
15.79
N/A
N/A
N/A
0.3739
Information Ratio
0.0423
N/A
0.0627
0.129
0.1145
N/A
(0.12)
0.021
Value At Risk
(2.86)
N/A
(0.26)
(50.00)
(0.50)
N/A
N/A
(0.44)
Expected Short fall
N/A
N/A
N/A
(75.00)
N/A
N/A
N/A
(1.32)
Downside Deviation
N/A
N/A
N/A
45.43
N/A
N/A
N/A
1.39
Semi Variance
N/A
N/A
N/A
249.3
N/A
N/A
N/A
0.1398

China Health Competition Performance Charts

Five steps to successful analysis of China Health Competition

China Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by China Health Management in relation to its competition. China Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of China Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact China Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to China Health Management, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your China Health position

In addition to having China Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Tech Funds Thematic Idea Now

Tech Funds
Tech Funds Theme
Funds or Etfs that invest in companies involved in research, development, testing, or distribution of technologically based goods and services. The Tech Funds theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in China Pink Sheet

China Health financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Health security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY